Experic Raises Additional Capital In Series B Extension To Support Additional Analytical Laboratory And Spray Drying Investments
Round Type
Series B
Description
Experic, a contract development and manufacturing organization (CDMO) and clinical supply services company serving the biopharmaceutical industry, announced today the successful completion of a Series B extension round of financing. The additional capital is earmarked to support the company's double-digit organic growth and strategic investments in key operational assets.
Who else raised in pharmaceuticals and Manufacturing around the same time
Companies in the same sectors as Experic that raised within 45 days of this round, from Fundz verified event records.
- Nucleus RadioPharma raised $66M on September 15, 2023.
- Nature's Toolbox raised $48M (Series B) on November 16, 2023.
- Route 92 Medical raised $31M (Series F) on November 16, 2023.
- Route 92 Medical raised $31M on November 15, 2023.
- Vittoria raised $15M (Funding Round) on November 14, 2023.
- SURGLASSES raised $6.5M (Funding Round) on November 9, 2023.
Who to call at Experic, and when
A new round usually means Experic is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Experic raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Experic, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Experic. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Experic raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansExperic raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.